Table 2

Cyclin D1 and clinicopathological characteristics of 32 patients with primary ovarian malignant tumors

CovariateNo. of patientsMedian cyclin D1(range)Kruskal-Wallis statisticsp
Overall320.30 (0.03–2.33)
Age (yrs)
 ≤58160.39 (0.03–2.00)0.0000081.000
 >58160.28 (0.03–2.33)
ECOG PSa
 090.61 (0.03–1.38)0.1430.705
 ≥1140.30 (0.06–2.33)
Histology
 Endometrioid90.07 (0.03–2.33)7.4540.058
 Serous150.61 (0.06–2.00)
 Mucinous20.13 (0.05–0.21)
 Other50.66 (0.16–1.16)
Residual disease
 ≤2 cm140.15 (0.03–1.78)1.3000.254
 >2 cm130.43 (0.06–2.33)
Grading
 150.07 (0.05–0.66)4.1370.126
 2100.27 (0.03–2.33)
 3160.48 (0.06–1.78)
FIGO stageb
 I–II70.05 (0.03–0.61)8.3820.003
 III–IV250.43 (0.06–2.33)
  • a ECOG PS, Eastern Cooperative Oncology Group performance status; unknown cases are not listed.

  • b FIGO, Fédération Internationale des Gynaecologistes et Obstetristes.